Table 2 Number of significant differentially methylated CpG sites before and after the surgery before and after adjustment for clinical variables (n = 30).
Model | Number of Bonferroni corrected significant CpG sites (% decrease from model 1) |
|---|---|
Model 1 (adjusted for cell type distribution) | 3649 |
Model 1 + BMI | 1813 (51%) |
Model 1 + insulin | 1686 (54%) |
Model 1 + CRP | 3294 (10%) |
Model 1 + glucose | 3415 (6%) |
Model 1 + BMI+ insulin + CRP + glucose | 1386 (62%) |